1. Home
  2. BIO vs KNSL Comparison

BIO vs KNSL Comparison

Compare BIO & KNSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$299.97

Market Cap

8.2B

Sector

Industrials

ML Signal

N/A

Logo Kinsale Capital Group Inc.

KNSL

Kinsale Capital Group Inc.

N/A

Current Price

$380.41

Market Cap

8.8B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BIO
KNSL
Founded
1952
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Property-Casualty Insurers
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.8B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
BIO
KNSL
Price
$299.97
$380.41
Analyst Decision
Strong Buy
Buy
Analyst Count
4
10
Target Price
$358.50
$483.78
AVG Volume (30 Days)
163.5K
258.8K
Earning Date
10-29-2025
10-23-2025
Dividend Yield
N/A
0.18%
EPS Growth
N/A
16.09
EPS
N/A
20.35
Revenue
$2,557,500,000.00
$1,802,839,000.00
Revenue This Year
$1.77
$19.56
Revenue Next Year
$2.30
$7.74
P/E Ratio
N/A
$18.93
Revenue Growth
N/A
18.10
52 Week Low
$211.43
$349.00
52 Week High
$373.69
$512.76

Technical Indicators

Market Signals
Indicator
BIO
KNSL
Relative Strength Index (RSI) 38.48 46.87
Support Level $298.02 $349.00
Resistance Level $319.50 $401.15
Average True Range (ATR) 8.25 10.33
MACD -2.25 3.49
Stochastic Oscillator 3.23 60.81

Price Performance

Historical Comparison
BIO
KNSL

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About KNSL Kinsale Capital Group Inc.

Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.

Share on Social Networks: